1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Pancreatic Cancer - Pipeline Review, 2015

Pancreatic Cancer - Pipeline Review, 2015

  • October 2015
  • -
  • Global Data
  • -
  • 107 pages

Pancreatic Cancer - Pipeline Review, 2015

Summary

GlobalData's Medical Devices sector report, “Pancreatic Cancer - Pipeline Review, 2015" provides an overview of Pancreatic Cancer diagnostic tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Pancreatic Cancer diagnostic tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Pancreatic Cancer diagnostic tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Pancreatic Cancer diagnostic tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Pancreatic Cancer diagnostic tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table Of Contents

Pancreatic Cancer - Pipeline Review, 2015
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 10
2 Introduction 11
2.1 Pancreatic Cancer Overview 11
3 Products under Development 12
3.1 Pancreatic Cancer - Pipeline Products by Stage of Development 12
3.2 Pancreatic Cancer - Pipeline Products by Territory 13
3.3 Pancreatic Cancer - Pipeline Products by Regulatory Path 14
3.4 Pancreatic Cancer - Pipeline Products by Estimated Approval Date 15
4 Pancreatic Cancer - Pipeline Products under Development by Companies 16
4.1 Pancreatic Cancer Companies - Pipeline Products by Stage of Development 16
4.2 Pancreatic Cancer - Pipeline Products by Stage of Development 19
5 Pancreatic Cancer Companies and Product Overview 21
5.1 AandG Pharmaceutical, Inc. Company Overview 21
5.1.1 AandG Pharmaceutical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 21
5.2 Abcodia Ltd. Company Overview 23
5.2.1 Abcodia Ltd. Pipeline Products and Ongoing Clinical Trials Overview 23
5.3 Acobiom Company Overview 24
5.3.1 Acobiom Pipeline Products and Ongoing Clinical Trials Overview 24
5.4 Andraka Technologies, LLC Company Overview 25
5.4.1 Andraka Technologies, LLC Pipeline Products and Ongoing Clinical Trials Overview 25
5.5 Applied Proteomics, Inc. Company Overview 26
5.5.1 Applied Proteomics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 26
5.6 Asuragen, Inc. Company Overview 27
5.6.1 Asuragen, Inc. Pipeline Products and Ongoing Clinical Trials Overview 27
5.7 BioMarker Strategies, LLC Company Overview 28
5.7.1 BioMarker Strategies, LLC Pipeline Products and Ongoing Clinical Trials Overview 28
5.8 Biouniversa s.r.l. Company Overview 29
5.8.1 Biouniversa s.r.l. Pipeline Products and Ongoing Clinical Trials Overview 29
5.9 Cancer Research Technology Limited Company Overview 31
5.9.1 Cancer Research Technology Limited Pipeline Products and Ongoing Clinical Trials Overview 31
5.10 Cellmid Limited Company Overview 32
5.10.1 Cellmid Limited Pipeline Products and Ongoing Clinical Trials Overview 32
5.11 Cepheid Company Overview 33
5.11.1 Cepheid Pipeline Products and Ongoing Clinical Trials Overview 33
5.12 Chronix Biomedical, Inc. Company Overview 35
5.12.1 Chronix Biomedical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 35
5.13 Cleveland Diagnostics Inc. Company Overview 37
5.13.1 Cleveland Diagnostics Inc. Pipeline Products and Ongoing Clinical Trials Overview 37
5.14 Clovis Oncology, Inc. Company Overview 38
5.14.1 Clovis Oncology, Inc. Pipeline Products and Ongoing Clinical Trials Overview 38
5.15 CompanDX Ltd. Company Overview 40
5.15.1 CompanDX Ltd. Pipeline Products and Ongoing Clinical Trials Overview 40
5.16 Courtagen Life Sciences, Inc. Company Overview 41
5.16.1 Courtagen Life Sciences, Inc. Pipeline Products and Ongoing Clinical Trials Overview 41
5.17 CS-Keys, Inc. Company Overview 42
5.17.1 CS-Keys, Inc. Pipeline Products and Ongoing Clinical Trials Overview 42
5.18 Dartmouth College Company Overview 43
5.18.1 Dartmouth College Pipeline Products and Ongoing Clinical Trials Overview 43
5.19 Di.V.A.L Toscana srl Company Overview 45
5.19.1 Di.V.A.L Toscana srl Pipeline Products and Ongoing Clinical Trials Overview 45
5.20 Exact Sciences Corporation Company Overview 46
5.20.1 Exact Sciences Corporation Pipeline Products and Ongoing Clinical Trials Overview 46
5.21 GeneFluidics Inc. Company Overview 48
5.21.1 GeneFluidics Inc. Pipeline Products and Ongoing Clinical Trials Overview 48
5.22 German Cancer Research Center Company Overview 49
5.22.1 German Cancer Research Center Pipeline Products and Ongoing Clinical Trials Overview 49
5.23 GlycoZym Company Overview 50
5.23.1 GlycoZym Pipeline Products and Ongoing Clinical Trials Overview 50
5.24 Health Discovery Corporation Company Overview 51
5.24.1 Health Discovery Corporation Pipeline Products and Ongoing Clinical Trials Overview 51
5.25 Hebrew University of Jerusalem Company Overview 53
5.25.1 Hebrew University of Jerusalem Pipeline Products and Ongoing Clinical Trials Overview 53
5.26 ImmunoCellular Therapeutics, Ltd. Company Overview 54
5.26.1 ImmunoCellular Therapeutics, Ltd. Pipeline Products and Ongoing Clinical Trials Overview 54
5.27 Immunomedics, Inc. Company Overview 56
5.27.1 Immunomedics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 56
5.28 Imperial College London Company Overview 58
5.28.1 Imperial College London Pipeline Products and Ongoing Clinical Trials Overview 58
5.29 IV Diagnostics, Inc. Company Overview 59
5.29.1 IV Diagnostics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 59
5.30 Matrix-Bio, Inc. Company Overview 60
5.30.1 Matrix-Bio, Inc. Pipeline Products and Ongoing Clinical Trials Overview 60
5.31 Mayo Clinic Company Overview 61
5.31.1 Mayo Clinic Pipeline Products and Ongoing Clinical Trials Overview 61
5.32 MDNA Life Sciences, Inc. Company Overview 62
5.32.1 MDNA Life Sciences, Inc. Pipeline Products and Ongoing Clinical Trials Overview 62
5.33 Merrimack Pharmaceuticals, Inc. Company Overview 63
5.33.1 Merrimack Pharmaceuticals, Inc. Pipeline Products and Ongoing Clinical Trials Overview 63
5.34 Metanomics Health GmbH Company Overview 65
5.34.1 Metanomics Health GmbH Pipeline Products and Ongoing Clinical Trials Overview 65
5.35 Milagen, Inc. Company Overview 66
5.35.1 Milagen, Inc. Pipeline Products and Ongoing Clinical Trials Overview 66
5.36 Miraculins Inc. Company Overview 67
5.36.1 Miraculins Inc. Pipeline Products and Ongoing Clinical Trials Overview 67
5.37 NanoScale Corporation Company Overview 69
5.37.1 NanoScale Corporation Pipeline Products and Ongoing Clinical Trials Overview 69
5.38 NatiMab Therapeutics S.r.l. Company Overview 70
5.38.1 NatiMab Therapeutics S.r.l. Pipeline Products and Ongoing Clinical Trials Overview 70
5.39 National Cheng-Kung University Hospital Company Overview 71
5.39.1 National Cheng-Kung University Hospital Pipeline Products and Ongoing Clinical Trials Overview 71
5.40 Neogenix Oncology, Inc. Company Overview 72
5.40.1 Neogenix Oncology, Inc. Pipeline Products and Ongoing Clinical Trials Overview 72
5.41 Onconome, Inc. Company Overview 73
5.41.1 Onconome, Inc. Pipeline Products and Ongoing Clinical Trials Overview 73
5.42 OPKO Health, Inc. Company Overview 75
5.42.1 OPKO Health, Inc. Pipeline Products and Ongoing Clinical Trials Overview 75
5.43 Oxford Gene Technology Limited Company Overview 77
5.43.1 Oxford Gene Technology Limited Pipeline Products and Ongoing Clinical Trials Overview 77
5.44 PeriRx LLC Company Overview 78
5.44.1 PeriRx LLC Pipeline Products and Ongoing Clinical Trials Overview 78
5.45 Precision Biologics, Inc. Company Overview 79
5.45.1 Precision Biologics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 79
5.46 Proplex Technologies, Llc Company Overview 80
5.46.1 Proplex Technologies, Llc Pipeline Products and Ongoing Clinical Trials Overview 80
5.47 Protagen AG Company Overview 82
5.47.1 Protagen AG Pipeline Products and Ongoing Clinical Trials Overview 82
5.48 SDIX, LLC Company Overview 83
5.48.1 SDIX, LLC Pipeline Products and Ongoing Clinical Trials Overview 83
5.49 Sienna Cancer Diagnostics Ltd Company Overview 85
5.49.1 Sienna Cancer Diagnostics Ltd Pipeline Products and Ongoing Clinical Trials Overview 85
5.50 SomaLogic, Inc. Company Overview 86
5.50.1 SomaLogic, Inc. Pipeline Products and Ongoing Clinical Trials Overview 86
5.51 Source MDx Company Overview 87
5.51.1 Source MDx Pipeline Products and Ongoing Clinical Trials Overview 87
5.52 Stanford University Company Overview 88
5.52.1 Stanford University Pipeline Products and Ongoing Clinical Trials Overview 88
5.53 The Johns Hopkins University Company Overview 89
5.53.1 The Johns Hopkins University Pipeline Products and Ongoing Clinical Trials Overview 89
5.54 Thomas Jefferson University Company Overview 93
5.54.1 Thomas Jefferson University Pipeline Products and Ongoing Clinical Trials Overview 93
5.55 US Biomarkers, Inc. Company Overview 94
5.55.1 US Biomarkers, Inc. Pipeline Products and Ongoing Clinical Trials Overview 94
5.56 Viomics Inc. Company Overview 95
5.56.1 Viomics Inc. Pipeline Products and Ongoing Clinical Trials Overview 95
5.57 Vitatex Inc. Company Overview 96
5.57.1 Vitatex Inc. Pipeline Products and Ongoing Clinical Trials Overview 96
5.58 VolitionRX Ltd. Company Overview 98
5.58.1 VolitionRX Ltd. Pipeline Products and Ongoing Clinical Trials Overview 98
6 Pancreatic Cancer- Recent Developments 100
7 Appendix 104
7.1 Methodology 104
7.2 About GlobalData 106
7.3 Contact Us 107
7.4 Disclaimer 107

1.1 List of Tables
Table 1: Pancreatic Cancer - Pipeline Products by Stage of Development 12
Table 2: Pancreatic Cancer - Pipeline Products by Territory 13
Table 3: Pancreatic Cancer - Pipeline Products by Regulatory Path 14
Table 4: Pancreatic Cancer - Pipeline Products by Estimated Approval Date 15
Table 5: Pancreatic Cancer Companies - Pipeline Products by Stage of Development 16
Table 6: Pancreatic Cancer - Pipeline Products by Stage of Development 19
Table 7: AandG Pharmaceutical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 21
Table 8: Companion Diagnostic Test - Pancreatic Cancer - Product Status 22
Table 9: Companion Diagnostic Test - Pancreatic Cancer - Product Description 22
Table 10: Abcodia Ltd. Pipeline Products and Ongoing Clinical Trials Overview 23
Table 11: Diagnostic Assay - Pancreatic Cancer - Product Status 23
Table 12: Diagnostic Assay - Pancreatic Cancer - Product Description 23
Table 13: Acobiom Pipeline Products and Ongoing Clinical Trials Overview 24
Table 14: Companion Diagnostic Assay - Pancreatic Cancer - Product Status 24
Table 15: Companion Diagnostic Assay - Pancreatic Cancer - Product Description 24
Table 16: Andraka Technologies, LLC Pipeline Products and Ongoing Clinical Trials Overview 25
Table 17: Diagnostic Test - Pancreatic Cancer - Product Status 25
Table 18: Diagnostic Test - Pancreatic Cancer - Product Description 25
Table 19: Applied Proteomics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 26
Table 20: API Diagnostic Test - Pancreatic Cancer - Product Status 26
Table 21: API Diagnostic Test - Pancreatic Cancer - Product Description 26
Table 22: Asuragen, Inc. Pipeline Products and Ongoing Clinical Trials Overview 27
Table 23: miRNA Pancreatic Cancer Test - Product Status 27
Table 24: miRNA Pancreatic Cancer Test - Product Description 27
Table 25: BioMarker Strategies, LLC Pipeline Products and Ongoing Clinical Trials Overview 28
Table 26: Ex Vivo Biomarker Test - Pancreatic Cancer - Product Status 28
Table 27: Ex Vivo Biomarker Test - Pancreatic Cancer - Product Description 28
Table 28: Biouniversa s.r.l. Pipeline Products and Ongoing Clinical Trials Overview 29
Table 29: BAG3 ELISA Kit - Pancreatic Cancer Diagnosis - Product Status 29
Table 30: BAG3 ELISA Kit - Pancreatic Cancer Diagnosis - Product Description 29
Table 31: BAG3 ELISA Kit - Pancreatic Cancer Early Diagnosis - Product Status 30
Table 32: BAG3 ELISA Kit - Pancreatic Cancer Early Diagnosis - Product Description 30
Table 33: Cancer Research Technology Limited Pipeline Products and Ongoing Clinical Trials Overview 31
Table 34: IHC Based Test - Pancreatic Cancer - Product Status 31
Table 35: IHC Based Test - Pancreatic Cancer - Product Description 31
Table 36: Cellmid Limited Pipeline Products and Ongoing Clinical Trials Overview 32
Table 37: MK Pan Cancer Marker Assay - Product Status 32
Table 38: MK Pan Cancer Marker Assay - Product Description 32
Table 39: Cepheid Pipeline Products and Ongoing Clinical Trials Overview 33
Table 40: Xpert Pancreatic CA Monitor Assay - Product Status 34
Table 41: Xpert Pancreatic CA Monitor Assay - Product Description 34
Table 42: Chronix Biomedical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 35
Table 43: Companion Diagnostic Test - Pancreatic Cancer - Product Status 36
Table 44: Companion Diagnostic Test - Pancreatic Cancer - Product Description 36
Table 45: Cleveland Diagnostics Inc. Pipeline Products and Ongoing Clinical Trials Overview 37
Table 46: Blood-Based Diagnostic Test - Pancreatic Cancer - Product Status 37
Table 47: Blood-Based Diagnostic Test - Pancreatic Cancer - Product Description 37
Table 48: Clovis Oncology, Inc. Pipeline Products and Ongoing Clinical Trials Overview 38
Table 49: hENT1 Companion Diagnostic Test - Product Status 39
Table 50: hENT1 Companion Diagnostic Test - Product Description 39
Table 51: CompanDX Ltd. Pipeline Products and Ongoing Clinical Trials Overview 40
Table 52: Biomarker Assay - Pancreatic Cancer - Product Status 40
Table 53: Biomarker Assay - Pancreatic Cancer - Product Description 40
Table 54: Courtagen Life Sciences, Inc. Pipeline Products and Ongoing Clinical Trials Overview 41
Table 55: Pancreatic Cancer Diagnostic Panel - Product Status 41
Table 56: Pancreatic Cancer Diagnostic Panel - Product Description 41
Table 57: CS-Keys, Inc. Pipeline Products and Ongoing Clinical Trials Overview 42
Table 58: caPCNA - Pancreatic Cancer - Product Status 42
Table 59: caPCNA - Pancreatic Cancer - Product Description 42
Table 60: Dartmouth College Pipeline Products and Ongoing Clinical Trials Overview 43
Table 61: ISH/IHC Assay - Pancreatic Cancer - Product Status 44
Table 62: ISH/IHC Assay - Pancreatic Cancer - Product Description 44
Table 63: Di.V.A.L Toscana srl Pipeline Products and Ongoing Clinical Trials Overview 45
Table 64: NanoMabKv - Pancreatic Cancer - Product Status 45
Table 65: NanoMabKv - Pancreatic Cancer - Product Description 45
Table 66: Exact Sciences Corporation Pipeline Products and Ongoing Clinical Trials Overview 46
Table 67: Diagnostic Assay - Pancreatic Cancer - Product Status 47
Table 68: Diagnostic Assay - Pancreatic Cancer - Product Description 47
Table 69: GeneFluidics Inc. Pipeline Products and Ongoing Clinical Trials Overview 48
Table 70: CA 19-9 Assay - Product Status 48
Table 71: CA 19-9 Assay - Product Description 48
Table 72: German Cancer Research Center Pipeline Products and Ongoing Clinical Trials Overview 49
Table 73: Diagnostic Assay - Pancreatic Cancer - Product Status 49
Table 74: Diagnostic Assay - Pancreatic Cancer - Product Description 49
Table 75: GlycoZym Pipeline Products and Ongoing Clinical Trials Overview 50
Table 76: Diagnostic Assay - Pancreatic Cancer - Product Status 50
Table 77: Diagnostic Assay - Pancreatic Cancer - Product Description 50
Table 78: Health Discovery Corporation Pipeline Products and Ongoing Clinical Trials Overview 51
Table 79: Diagnostic Test - Pancreatic Cancer - Product Status 52
Table 80: Diagnostic Test - Pancreatic Cancer - Product Description 52
Table 81: Hebrew University of Jerusalem Pipeline Products and Ongoing Clinical Trials Overview 53
Table 82: Diagnostic Assay - Pancreatic Cancer - Product Status 53
Table 83: Diagnostic Assay - Pancreatic Cancer - Product Description 53
Table 84: ImmunoCellular Therapeutics, Ltd. Pipeline Products and Ongoing Clinical Trials Overview 54
Table 85: Diagnostic Test - Pancreatic Cancer - Product Status 55
Table 86: Diagnostic Test - Pancreatic Cancer - Product Description 55
Table 87: Immunomedics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 56
Table 88: Diagnostic Assay - Pancreatic Cancer - Product Status 57
Table 89: Diagnostic Assay - Pancreatic Cancer - Product Description 57
Table 90: Imperial College London Pipeline Products and Ongoing Clinical Trials Overview 58
Table 91: Prognostic Assay - Pancreatic Cancer - Product Status 58
Table 92: Prognostic Assay - Pancreatic Cancer - Product Description 58
Table 93: IV Diagnostics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 59
Table 94: Diagnostic Test - Pancreatic Cancer - Product Status 59
Table 95: Diagnostic Test - Pancreatic Cancer - Product Description 59
Table 96: Matrix-Bio, Inc. Pipeline Products and Ongoing Clinical Trials Overview 60
Table 97: VeraMarker Pancreatic Cancer Test - Product Status 60
Table 98: VeraMarker Pancreatic Cancer Test - Product Description 60
Table 99: Mayo Clinic Pipeline Products and Ongoing Clinical Trials Overview 61
Table 100: Methylation Biomarker Test - Pancreatic Cancer - Product Status 61
Table 101: Methylation Biomarker Test - Pancreatic Cancer - Product Description 61
Table 102: MDNA Life Sciences, Inc. Pipeline Products and Ongoing Clinical Trials Overview 62
Table 103: Diagnostic Assay - Pancreatic Cancer - Product Status 62
Table 104: Diagnostic Assay - Pancreatic Cancer - Product Description 62
Table 105: Merrimack Pharmaceuticals, Inc. Pipeline Products and Ongoing Clinical Trials Overview 63
Table 106: MM-141 Companion Diagnostic Assay - Pancreatic Cancer - Product Status 64
Table 107: MM-141 Companion Diagnostic Assay - Pancreatic Cancer - Product Description 64
Table 108: Metanomics Health GmbH Pipeline Products and Ongoing Clinical Trials Overview 65
Table 109: Diagnostic Assay - Pancreatic Cancer - Product Status 65
Table 110: Diagnostic Assay - Pancreatic Cancer - Product Description 65
Table 111: Milagen, Inc. Pipeline Products and Ongoing Clinical Trials Overview 66
Table 112: Immunoassay - Pancreatic Cancer - Product Status 66
Table 113: Immunoassay - Pancreatic Cancer - Product Description 66
Table 114: Miraculins Inc. Pipeline Products and Ongoing Clinical Trials Overview 67
Table 115: Diagnostic Test - Pancreatic Cancer - Product Status 68
Table 116: Diagnostic Test - Pancreatic Cancer - Product Description 68
Table 117: NanoScale Corporation Pipeline Products and Ongoing Clinical Trials Overview 69
Table 118: Diagnostic Test - Pancreatic Cancer - Product Status 69
Table 119: Diagnostic Test - Pancreatic Cancer - Product Description 69
Table 120: NatiMab Therapeutics S.r.l. Pipeline Products and Ongoing Clinical Trials Overview 70
Table 121: Diagnostic Test - Pancreas Adenocarcinoma - Product Status 70
Table 122: Diagnostic Test - Pancreas Adenocarcinoma - Product Description 70
Table 123: National Cheng-Kung University Hospital Pipeline Products and Ongoing Clinical Trials Overview 71
Table 124: Diagnostic Biomarker - Pancreatic Cancer - Product Status 71
Table 125: Diagnostic Biomarker - Pancreatic Cancer - Product Description 71
Table 126: Neogenix Oncology, Inc. Pipeline Products and Ongoing Clinical Trials Overview 72
Table 127: Diagnostic Assay - Pancreatic Cancer - Product Status 72
Table 128: Diagnostic Assay - Pancreatic Cancer - Product Description 72
Table 129: Onconome, Inc. Pipeline Products and Ongoing Clinical Trials Overview 73
Table 130: Pan Cancer Screening and Detection Test - Product Status 73
Table 131: Pan Cancer Screening and Detection Test - Product Description 73
Table 132: Pan-Cancer Metastatic Marker Test - Product Status 74
Table 133: Pan-Cancer Metastatic Marker Test - Product Description 74
Table 134: OPKO Health, Inc. Pipeline Products and Ongoing Clinical Trials Overview 75
Table 135: Diagnostic Test - Pancreatic Cancer - Product Status 76
Table 136: Diagnostic Test - Pancreatic Cancer - Product Description 76
Table 137: Oxford Gene Technology Limited Pipeline Products and Ongoing Clinical Trials Overview 77
Table 138: Diagnostic Test - Pancreatic Cancer - Product Status 77
Table 139: Diagnostic Test - Pancreatic Cancer - Product Description 77
Table 140: PeriRx LLC Pipeline Products and Ongoing Clinical Trials Overview 78
Table 141: Saliva Test - Pancreatic Cancer - Product Status 78
Table 142: Saliva Test - Pancreatic Cancer - Product Description 78
Table 143: Precision Biologics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 79
Table 144: NEO-301 IHC Test - Product Status 79
Table 145: NEO-301 IHC Test - Product Description 79
Table 146: Proplex Technologies, Llc Pipeline Products and Ongoing Clinical Trials Overview 80
Table 147: Biomarker Diagnostic Test - Pancreatic Cancer - Product Status 81
Table 148: Biomarker Diagnostic Test - Pancreatic Cancer - Product Description 81
Table 149: Protagen AG Pipeline Products and Ongoing Clinical Trials Overview 82
Table 150: Diagnostic Assay - Pancreatic Cancer - Product Status 82
Table 151: Diagnostic Assay - Pancreatic Cancer - Product Description 82
Table 152: SDIX, LLC Pipeline Products and Ongoing Clinical Trials Overview 83
Table 153: Pancreatic Cancer Assay - Product Status 84
Table 154: Pancreatic Cancer Assay - Product Description 84
Table 155: Sienna Cancer Diagnostics Ltd Pipeline Products and Ongoing Clinical Trials Overview 85
Table 156: Sienna Test - Pancreatic Cancer - Product Status 85
Table 157: Sienna Test - Pancreatic Cancer - Product Description 85
Table 158: SomaLogic, Inc. Pipeline Products and Ongoing Clinical Trials Overview 86
Table 159: Diagnostic Assay - Pancreatic Cancer - Product Status 86
Table 160: Diagnostic Assay - Pancreatic Cancer - Product Description 86
Table 161: Source MDx Pipeline Products and Ongoing Clinical Trials Overview 87
Table 162: Precision Profile - Pancreatic Cancer - Product Status 87
Table 163: Precision Profile - Pancreatic Cancer - Product Description 87
Table 164: Stanford University Pipeline Products and Ongoing Clinical Trials Overview 88
Table 165: Biomarker Assay - Pancreatic Cyst - Product Status 88
Table 166: Biomarker Assay - Pancreatic Cyst - Product Description 88
Table 167: The Johns Hopkins University Pipeline Products and Ongoing Clinical Trials Overview 89
Table 168: Antigen Based Diagnostic Assay - Pancreatic Cancer - Product Status 90
Table 169: Antigen Based Diagnostic Assay - Pancreatic Cancer - Product Description 90
Table 170: Protein Biomarker Assay - Pancreatic Cancer - Product Status 91
Table 171: Protein Biomarker Assay - Pancreatic Cancer - Product Description 91
Table 172: Protein Biomarker Assay - Pancreatic Cancer - Product Status 92
Table 173: Protein Biomarker Assay - Pancreatic Cancer - Product Description 92
Table 174: Thomas Jefferson University Pipeline Products and Ongoing Clinical Trials Overview 93
Table 175: Diagnostic Test - Pancreatic Cancer - Product Status 93
Table 176: Diagnostic Test - Pancreatic Cancer - Product Description 93
Table 177: US Biomarkers, Inc. Pipeline Products and Ongoing Clinical Trials Overview 94
Table 178: Blood-Based Biomarker - Pancreatic Cancer - Product Status 94
Table 179: Blood-Based Biomarker - Pancreatic Cancer - Product Description 94
Table 180: Viomics Inc. Pipeline Products and Ongoing Clinical Trials Overview 95
Table 181: Viomics Diagnostic Assay - Pancreatic Cancer - Product Status 95
Table 182: Viomics Diagnostic Assay - Pancreatic Cancer - Product Description 95
Table 183: Vitatex Inc. Pipeline Products and Ongoing Clinical Trials Overview 96
Table 184: Pancreatic Cancer CTC Detection Kit - Product Status 97
Table 185: Pancreatic Cancer CTC Detection Kit - Product Description 97
Table 186: VolitionRX Ltd. Pipeline Products and Ongoing Clinical Trials Overview 98
Table 187: NuQ Diagnostic Test - Pancreatic Cancer - Product Status 99
Table 188: NuQ Diagnostic Test - Pancreatic Cancer - Product Description 99
Table 189: Glossary 105

1.2 List of Figures
Figure 1: Pancreatic Cancer - Pipeline Products by Stage of Development 12
Figure 2: Pancreatic Cancer - Pipeline Products by Territory 13
Figure 3: Pancreatic Cancer - Pipeline Products by Regulatory Path 14
Figure 4: Pancreatic Cancer - Pipeline Products by Estimated Approval Date 15

Companies Mentioned
AandG Pharmaceutical, Inc.
Abcodia Ltd.
Acobiom
Andraka Technologies, LLC
Applied Proteomics, Inc.
Asuragen, Inc.
BioMarker Strategies, LLC
Biouniversa s.r.l.
Cancer Research Technology Limited
Cellmid Limited
Cepheid
Chronix Biomedical, Inc.
Cleveland Diag

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Pancreatic Cancer: Analytical Tool

Pancreatic Cancer: Analytical Tool

  • $ 8096
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Pancreatic Cancer - Market Insights, Epidemiology and Market  Forecast-2023

Pancreatic Cancer - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Pancreatic Cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global ...

Pancreatic Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Pancreatic Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

  • $ 4000
  • Industry report
  • December 2016
  • by Global Data

Pancreatic Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Pancreatic Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, ...


Download Unlimited Documents from Trusted Public Sources

Cancer Statistics in the US

  • December 2016
    112 pages
  • Cancer  

  • United States  

    North America  

View report >

Cancer Statistics in the UK

  • November 2016
    51 pages
  • Cancer  

    Therapy  

    Oncology  

  • United Kingdom  

    Europe  

View report >

Cancer Statistics in the UK

  • November 2016
    20 pages
  • Cancer  

    Blood Transfusi...  

  • United Kingdom  

    United States  

View report >

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.